DigniCap® scalp cooling system

The DigniCap® system is the first and only scalp cooling device to complete rigorous FDA clinical trials where seven out of 10 patients with early-stage breast cancer kept at least 50% of their hair.

Contact Us

Charleston Oncology has the DigniCap® System, which is FDA approved for women with breast cancer!

The machine works by cooling the scalp causing a reduced blood flow to that area so that less chemotherapy reaches the hair cells. Therefore this reduces chemotherapy-induced hair loss. Prior to this system, patients were required to use manual cold caps kept in freezers and dry ice. Patients would have to change them every 30 minutes to ensure the scalp would remain chilled. Now, you can sit comfortably in your chair with a fitted cap for the duration of your treatment.

This treatment is not covered by your insurance. Please call for pricing on this treatment and to set up an appointment with one of our physicians.

Visit www.dignicap.com for more information.

Choose your preferred location

West Ashley

North Charleston

Downtown

Summerville

Mt. Pleasant

Walterboro

Send UsA Message

LOCATION*

PROVIDER*

FIRST NAME*

LAST NAME*

EMAIL ADDRESS*

PHONE*

Birthdate*

MESSAGE

I understand and agree that any information submitted will be forwarded to our office by email and not via a secure messaging system. This form should not be used to transmit private health information, and we disclaim all warranties with respect to the privacy and confidentiality of any information submitted through this form.*

Welcome Social Worker Elizabeth Robinson

May 22, 2021

Possessing the values of acceptance, tolerance, and genuine care, Liz is an embodiment of the field of Social Work. “I could not imagine my life without Social Work in it. It’s part of who I am,” shared Liz.

The Importance of Colorectal Cancer Screening

Mar 26, 2021

This Colorectal Cancer Awareness Month, Charleston Oncology joins the national effort to spread awareness about the disease and the importance of regular screenings.